This will add on to the nearly 5,000 stores across 34 US states that have already stocked its products following US FDA’s approval of its products to curb the country’s formula shortage.
The two newly added chains are Meijer and HEB retail groups. The former is a supermarket chain based in Texas with 340 stores, while the latter owns 259 stores located predominantly in the Midwest, including Michigan, Illinois, Indiana, Kentucky, Ohio, and Wisconsin.
“There were over 365,000 births in Texas in 2020, compared to around 300,000 in all of Australia.
“Similar to others, the state has experienced stock shortage and is a primary focus for the distribution roll-out,” Bubs said in an ASX-filing on July 4.
Prior to this, Bubs has struck deals with Target, Walmart, Kroger, and Albertsons.
By mid of this month, Bubs expects 361,299 cans of its Bubs Infant Formula to be sold across 34 US states.
In addition, its infant formula sold in the US will receive tariff concession under the Australia US Free Trade Agreement, following discussions between the two governments and stakeholders.
The firm received the enforcement discretion from the US FDA to import six of its infant formula products on May 27.
“In under a month, six Bubs Australia (ASX:BUB) infant formula products are on shelves in close to 5,000 stores across 34 States, with more to come,” Bubs Australia chairman, Dennis Lin said in a Linkedin post on June 30.
“We will next include focus on consumer education and awareness of our infant formula products. Only several weeks ago, it’s a milestone we thought must be at least 12 months away,” he added.
The following is a list of the US retailers and the number of stores that are selling Bubs’ infant formula.
Last week, 22 US state agencies have also authorised Bubs infant formula products under a government program that provide subsidies to women, infants, and children for nutrition products.
Known as the Special Supplement Nutrition Program for Women, Infants and Children (WIC Program), it accounts for over 50 pre cent formula consumption in the country.
Behind the scenes
Lin revealed that the firm took 12 hours to put in its FDA submission and 24 days from FDA’s discretion to stock its products on shelves.
The firm expects its FY22 gross revenue to exceed AUD$100m (US$68.2m) and achieve over AUD$2.4m in underlying EBITDA, it said on July 5.
It has also managed to raise AUD$63m to support growth opportunities, including expanding canning capability and operating expenses in the US.
The firm first entered the US market last June with its toddler products.